CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Gate2Brain is a technology platform that utilizes small peptide shuttles to transport therapeutic agents across the blood-brain barrier, addressing the challenge of treating central nervous system disorders. Its flagship product targets pediatric brain tumors, offering a non-invasive delivery method.
In 2019, 30 million people worldwide were diagnosed with some form of CNS disorder and most of them lack effective treatment.
This is largely explained by the fact that most of developed therapeutic molecules do not contain the appropriate properties to cross the BBB.
Consequently, CNS disorders are the first cause of disability, and the second of mortality worldwide.
Gate2Brain is a technologic platform based on a set of small peptide-shuttles that have the capacity to cross the BBB and carry t…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
